BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 24817014)

  • 1. Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease.
    Nkuipou-Kenfack E; Duranton F; Gayrard N; Argilés À; Lundin U; Weinberger KM; Dakna M; Delles C; Mullen W; Husi H; Klein J; Koeck T; Zürbig P; Mischak H
    PLoS One; 2014; 9(5):e96955. PubMed ID: 24817014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Kwan B; Fuhrer T; Zhang J; Darshi M; Van Espen B; Montemayor D; de Boer IH; Dobre M; Hsu CY; Kelly TN; Raj DS; Rao PS; Saraf SL; Scialla J; Waikar SS; Sharma K; Natarajan L;
    Am J Kidney Dis; 2020 Oct; 76(4):511-520. PubMed ID: 32387023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Urinary Biomarkers For Improved Prediction Of Progressive Egfr Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease.
    Rodríguez-Ortiz ME; Pontillo C; Rodríguez M; Zürbig P; Mischak H; Ortiz A
    Sci Rep; 2018 Oct; 8(1):15940. PubMed ID: 30374033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and urinary amino acid metabolomic profiling in patients with different levels of kidney function.
    Duranton F; Lundin U; Gayrard N; Mischak H; Aparicio M; Mourad G; Daurès JP; Weinberger KM; Argilés A
    Clin J Am Soc Nephrol; 2014 Jan; 9(1):37-45. PubMed ID: 24235289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of the CKD273 peptide classifier in predicting chronic kidney disease progression.
    Critselis E; Lambers Heerspink H
    Nephrol Dial Transplant; 2016 Feb; 31(2):249-54. PubMed ID: 25791724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Uromodulin Correlates With Kidney Function and Identifies Early Stages in Chronic Kidney Disease Patients.
    Steubl D; Block M; Herbst V; Nockher WA; Schlumberger W; Satanovskij R; Angermann S; Hasenau AL; Stecher L; Heemann U; Renders L; Scherberich J
    Medicine (Baltimore); 2016 Mar; 95(10):e3011. PubMed ID: 26962815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The urinary proteome as correlate and predictor of renal function in a population study.
    Gu YM; Thijs L; Liu YP; Zhang Z; Jacobs L; Koeck T; Zürbig P; Lichtinghagen R; Brand K; Kuznetsova T; Olivi L; Verhamme P; Delles C; Mischak H; Staessen JA
    Nephrol Dial Transplant; 2014 Dec; 29(12):2260-8. PubMed ID: 24981581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic and metabolomic approaches in the search for biomarkers in chronic kidney disease.
    Cañadas-Garre M; Anderson K; McGoldrick J; Maxwell AP; McKnight AJ
    J Proteomics; 2019 Feb; 193():93-122. PubMed ID: 30292816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased urinary osmolyte excretion indicates chronic kidney disease severity and progression rate.
    Gil RB; Ortiz A; Sanchez-Niño MD; Markoska K; Schepers E; Vanholder R; Glorieux G; Schmitt-Kopplin P; Heinzmann SS
    Nephrol Dial Transplant; 2018 Dec; 33(12):2156-2164. PubMed ID: 29554320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A urinary proteome-based classifier for the early detection of decline in glomerular filtration.
    Pontillo C; Jacobs L; Staessen JA; Schanstra JP; Rossing P; Heerspink HJL; Siwy J; Mullen W; Vlahou A; Mischak H; Vanholder R; Zürbig P; Jankowski J
    Nephrol Dial Transplant; 2017 Sep; 32(9):1510-1516. PubMed ID: 27387473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
    Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
    Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Glycolytic Enzymes and Pyruvate Kinase M2 in Type 1 and 2 Diabetic Nephropathy.
    Gordin D; Shah H; Shinjo T; St-Louis R; Qi W; Park K; Paniagua SM; Pober DM; Wu IH; Bahnam V; Brissett MJ; Tinsley LJ; Dreyfuss JM; Pan H; Dong Y; Niewczas MA; Amenta P; Sadowski T; Kannt A; Keenan HA; King GL
    Diabetes Care; 2019 Jul; 42(7):1263-1273. PubMed ID: 31076418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary cell-free mitochondrial and nuclear deoxyribonucleic acid correlates with the prognosis of chronic kidney diseases.
    Chang CC; Chiu PF; Wu CL; Kuo CL; Huang CS; Liu CS; Huang CH
    BMC Nephrol; 2019 Oct; 20(1):391. PubMed ID: 31660901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretransplant urinary proteome analysis does not predict development of chronic kidney disease after liver transplantation.
    Milongo D; Bascands JL; Huart A; Esposito L; Breuil B; Moulos P; Siwy J; Ramírez-Torres A; Ribes D; Lavayssière L; Del Bello A; Muscari F; Alric L; Bureau C; Rostaing L; Schanstra JP; Kamar N
    Liver Int; 2015 Jul; 35(7):1893-901. PubMed ID: 25515948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency Cohort Study.
    Rhee EP; Clish CB; Wenger J; Roy J; Elmariah S; Pierce KA; Bullock K; Anderson AH; Gerszten RE; Feldman HI
    Am J Nephrol; 2016; 43(5):366-74. PubMed ID: 27172772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolite Biomarkers of CKD Progression in Children.
    Denburg MR; Xu Y; Abraham AG; Coresh J; Chen J; Grams ME; Feldman HI; Kimmel PL; Rebholz CM; Rhee EP; Vasan RS; Warady BA; Furth SL;
    Clin J Am Soc Nephrol; 2021 Aug; 16(8):1178-1189. PubMed ID: 34362785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary peptide biomarker panel associated with an improvement in estimated glomerular filtration rate in chronic kidney disease patients.
    Markoska K; Pejchinovski M; Pontillo C; Zürbig P; Jacobs L; Smith A; Masin-Spasovska J; Stojceva-Taneva O; Polenakovic M; Magni F; Mischak H; Spasovski G
    Nephrol Dial Transplant; 2018 May; 33(5):751-759. PubMed ID: 28992073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of urine proteomics biomarker and disease progression in patients with IgA nephropathy.
    Peters B; Beige J; Siwy J; Rudnicki M; Wendt R; Ortiz A; Sanz AB; Mischak H; Reich HN; Nasic S; Mahmood D; Persson A; Fernström A; Weiner M; Stegmayr B;
    Nephrol Dial Transplant; 2023 Nov; 38(12):2826-2834. PubMed ID: 37349951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary peptidomic biomarkers of renal function in heart transplant recipients.
    Huang QF; Zhang ZY; Van Keer J; Trenson S; Nkuipou-Kenfack E; Yang WY; Thijs L; Vanhaecke J; Van Aelst LNL; Van Cleemput J; Janssens S; Verhamme P; Mischak H; Staessen JA
    Nephrol Dial Transplant; 2019 Aug; 34(8):1336-1343. PubMed ID: 29982668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CKD273, a new proteomics classifier assessing CKD and its prognosis.
    Argilés Á; Siwy J; Duranton F; Gayrard N; Dakna M; Lundin U; Osaba L; Delles C; Mourad G; Weinberger KM; Mischak H
    PLoS One; 2013; 8(5):e62837. PubMed ID: 23690958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.